23.02.2016 14:35:10
|
ANI Pharma Q4 Profit Plunges
(RTTNews) - ANI Pharmaceuticals Inc. (ANIP) Tuesday announced fourth quarter net income of $2.876 million or $0.25 per share, compared to $21.006 million or $1.82 per share last year. On an adjusted basis, net income was $6.042 million or $0.52 per share.
On average, 3 analysts polled by Thomson Reuters expected the company to earn $0.60 per share. Analysts estimates usually exclude special items.
Revenue for the quarter declined to $18.035 from $21.037 million in the previous year. Wall Street expected $18.13 million.
Looking ahead to full year 2016, the company expects earnings per share to be $0.30 to $0.65 and adjusted net income per share to be between $2.94 to $3.31. Street projects $2.99 per share on revenue of $91.83 million.
Revenue for the quarter in expected to be between $105 million to $120 million.
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Biosante Pharmaceuticals Incmehr Nachrichten
Keine Nachrichten verfügbar. |